Patents by Inventor Diane D. Harrison

Diane D. Harrison has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240150454
    Abstract: The present invention relates to compositions and methods utilizing anti-TNF antibodies having a heavy chain (HC) comprising SEQ ID NO:36 and a light chain (LC) comprising SEQ ID NO:37 for use in the safe and effective treatment of active Ankylosing Spondylitis (AS).
    Type: Application
    Filed: November 1, 2023
    Publication date: May 9, 2024
    Inventors: Diane D. Harrison, Elizabeth C. Hsia, Lee-Lian Kim, Kim Hung Lo
  • Publication number: 20230158044
    Abstract: The present invention relates to monolithic intravaginal rings comprising progesterone, methods of making, and uses thereof. The intravaginal rings comprise progesterone, a polysiloxane elastomer, and a pharmaceutically acceptable hydrocarbon or glycerol esters of a fatty acid.
    Type: Application
    Filed: July 5, 2022
    Publication date: May 25, 2023
    Applicant: Ferring B.V.
    Inventors: Salah U. Ahmed, Jiaxiang TSAO, Anu MAHASHABDE, Diane D. HARRISON
  • Publication number: 20220324959
    Abstract: The present invention relates to compositions and methods utilizing anti-TNF antibodies or antigen binding fragments thereof in a treatment of active Ankylosing Spondylitis (AS), e.g., a treatment utilizing the anti-TNF antibody having a heavy chain (HC) comprising SEQ ID NO:36 and a light chain (LC) comprising SEQ ID NO:37.
    Type: Application
    Filed: May 11, 2020
    Publication date: October 13, 2022
    Inventors: Diane D. Harrison, Elizabeth C. Hsia, Lee-Lian Kim, Kim Hung Lo
  • Publication number: 20220323580
    Abstract: The present invention relates to compositions and methods utilizing anti-TNF antibodies or antigen binding fragments thereof in a treatment for active Psoriatic Arthritis (PsA), e.g., a treatment utilizing the anti-TNF antibody having a heavy chain (HC) comprising amino acid sequence SEQ ID NO:36 and a light chain (LC) comprising amino acid sequence SEQ ID NO:37.
    Type: Application
    Filed: May 11, 2020
    Publication date: October 13, 2022
    Inventors: Diane D. Harrison, Elizabeth C. Hsia, Lee-Lian Kim, Kim Hung Lo
  • Patent number: 11413294
    Abstract: The present invention relates to monolithic intravaginal rings comprising progesterone, methods of making, and uses thereof. The intravaginal rings comprise progesterone, a polysiloxane elastomer, and a pharmaceutically acceptable hydrocarbon or glycerol esters of a fatty acid.
    Type: Grant
    Filed: January 31, 2020
    Date of Patent: August 16, 2022
    Assignee: FERRING B.V.
    Inventors: Salah U. Ahmed, Jiaxiang Tsao, Anu Mahashabde, Diane D. Harrison
  • Publication number: 20220195028
    Abstract: The present invention relates to compositions and methods utilizing anti-TNF antibodies or antigen binding fragments thereof in a treatment of active Ankylosing Spondylitis (AS), e.g., a treatment utilizing the anti-TNF antibody having heavy chain complementarity-determining region (CDR) amino acid sequences SEQ ID NOS:40-42 and light chain CDR amino acid sequences SEQ ID NOS:43-45.
    Type: Application
    Filed: December 16, 2021
    Publication date: June 23, 2022
    Inventors: Diane D. Harrison, Elizabeth C. Hsia, Lee-Lian Kim, Kim Hung Lo
  • Publication number: 20220064278
    Abstract: The present invention relates to compositions and methods utilizing anti-TNF antibodies having a heavy chain (HC) comprising amino acid sequence SEQ ID NO:36 and a light chain (LC) comprising amino acid sequence SEQ ID NO:37 in a treatment for active Psoriatic Arthritis (PsA).
    Type: Application
    Filed: January 14, 2020
    Publication date: March 3, 2022
    Inventors: Diane D. Harrison, Elizabeth C. Hsia, Lee-Lian Kim, Kim Hung Lo
  • Publication number: 20210277104
    Abstract: The present invention relates to compositions and methods utilizing anti-TNF antibodies having a heavy chain (HC) comprising SEQ ID NO:36 and a light chain (LC) comprising SEQ ID NO:37 for use in the safe and effective treatment of active Psoriatic Arthritis (PsA).
    Type: Application
    Filed: May 14, 2021
    Publication date: September 9, 2021
    Inventors: Diane D. Harrison, Elizabeth C. Hsia, Lee-Lian Kim, Kim Hung Lo
  • Publication number: 20210238271
    Abstract: The present invention relates to compositions and methods utilizing anti-TNF antibodies having a heavy chain (HC) comprising SEQ ID NO:36 and a light chain (LC) comprising SEQ ID NO:37 for use in the safe and effective treatment of active Ankylosing Spondylitis (AS).
    Type: Application
    Filed: April 22, 2021
    Publication date: August 5, 2021
    Inventors: Diane D. Harrison, Elizabeth C. Hsia, Lee-Lian Kim, Kim Hung Lo
  • Patent number: 11041020
    Abstract: The present invention relates to compositions and methods utilizing anti-TNF antibodies having a heavy chain (HC) comprising SEQ ID NO:36 and a light chain (LC) comprising SEQ ID NO:37 for use in the safe and effective treatment of active Psoriatic Arthritis (PsA).
    Type: Grant
    Filed: July 20, 2019
    Date of Patent: June 22, 2021
    Assignee: JANSSEN BIOTECH, INC.
    Inventors: Diane D. Harrison, Elizabeth C. Hsia, Lee-Lian Kim, Kim Hung Lo
  • Patent number: 11014982
    Abstract: The present invention relates to compositions and methods utilizing anti-TNF antibodies having a heavy chain (HC) comprising SEQ ID NO:36 and a light chain (LC) comprising SEQ ID NO:37 for use in the safe and effective treatment of active Ankylosing Spondylitis (AS).
    Type: Grant
    Filed: July 20, 2019
    Date of Patent: May 25, 2021
    Assignee: JANSSEN BIOTECH, INC.
    Inventors: Diane D. Harrison, Elizabeth C. Hsia, Lee-Lian Kim, Kim Hung Lo
  • Publication number: 20200405732
    Abstract: The present invention relates to monolithic intravaginal rings comprising progesterone, methods of making, and uses thereof. The intravaginal rings comprise progesterone, a polysiloxane elastomer, and a pharmaceutically acceptable hydrocarbon or glycerol esters of a fatty acid.
    Type: Application
    Filed: January 31, 2020
    Publication date: December 31, 2020
    Applicant: Ferring B.V.
    Inventors: Salah U. Ahmed, Jiaxiang TSAO, Anu MAHASHABDE, Diane D. HARRISON
  • Patent number: 10548904
    Abstract: The present invention relates to monolithic intravaginal rings comprising progesterone, methods of making, and uses thereof. The intravaginal rings comprise progesterone, a polysiloxane elastomer, and a pharmaceutically acceptable hydrocarbon or glycerol esters of a fatty acid.
    Type: Grant
    Filed: October 3, 2013
    Date of Patent: February 4, 2020
    Assignee: FERRING B.V.
    Inventors: Salah U. Ahmed, Jiaxiang Tsao, Anu Mahashabde, Diane D. Harrison
  • Patent number: 10537584
    Abstract: The present invention relates to monolithic intravaginal rings comprising progesterone, methods of making, and uses thereof. The intravaginal rings comprise progesterone, a polysiloxane elastomer, and a pharmaceutically acceptable hydrocarbon or glycerol esters of a fatty acid.
    Type: Grant
    Filed: June 8, 2016
    Date of Patent: January 21, 2020
    Assignee: FERRING B.V.
    Inventors: Salah U. Ahmed, Jiaxiang Tsao, Anu Mahashabde, Diane D. Harrison
  • Publication number: 20190345244
    Abstract: The present invention relates to compositions and methods utilizing anti-TNF antibodies having a heavy chain (HC) comprising SEQ ID NO:36 and a light chain (LC) comprising SEQ ID NO:37 for use in the safe and effective treatment of active Ankylosing Spondylitis (AS).
    Type: Application
    Filed: July 20, 2019
    Publication date: November 14, 2019
    Applicant: Janssen Biotech, Inc.
    Inventors: Diane D. Harrison, Elizabeth C. Hsia, Lee-Lian Kim, Kim Hung Lo
  • Publication number: 20190338022
    Abstract: The present invention relates to compositions and methods utilizing anti-TNF antibodies having a heavy chain (HC) comprising SEQ ID NO:36 and a light chain (LC) comprising SEQ ID NO:37 for use in the safe and effective treatment of active Psoriatic Arthritis (PsA).
    Type: Application
    Filed: July 20, 2019
    Publication date: November 7, 2019
    Applicant: Janssen Biotech, Inc.
    Inventors: Diane D. Harrison, Elizabeth C. Hsia, Lee-Lian Kim, Kim Hung Lo
  • Publication number: 20180222972
    Abstract: The present invention relates to compositions and methods utilizing anti-TNF antibodies having a heavy chain (HC) comprising SEQ ID NO:36 and a light chain (LC) comprising SEQ ID NO:37 for use in the safe and effective treatment of active Ankylosing Spondylitis (AS).
    Type: Application
    Filed: November 20, 2017
    Publication date: August 9, 2018
    Applicant: Janssen Biotech, Inc.
    Inventors: Diane D. Harrison, Elizabeth C. Hsia, Lee-Lian Kim, Kim Hung Lo
  • Publication number: 20180215819
    Abstract: The present invention relates to compositions and methods utilizing anti-TNF antibodies having a heavy chain (HC) comprising SEQ ID NO:36 and a light chain (LC) comprising SEQ ID NO:37 for use in the safe and effective treatment of active Psoriatic Arthritis (PsA).
    Type: Application
    Filed: November 20, 2017
    Publication date: August 2, 2018
    Applicant: Janssen Biotech, Inc.
    Inventors: Diane D. Harrison, Elizabeth C. Hsia, Lee-Lian Kim, Kim Hung Lo
  • Publication number: 20160279147
    Abstract: The present invention relates to monolithic intravaginal rings comprising progesterone, methods of making, and uses thereof. The intravaginal rings comprise progesterone, a polysiloxane elastomer, and a pharmaceutically acceptable hydrocarbon or glycerol esters of a fatty acid.
    Type: Application
    Filed: June 8, 2016
    Publication date: September 29, 2016
    Applicant: FERRING B.V.
    Inventors: Salah U. AHMED, Jiaxiang TSAO, Anu MAHASHABDE, Diane D. HARRISON
  • Publication number: 20140030311
    Abstract: The present invention relates to monolithic intravaginal rings comprising progesterone, methods of making, and uses thereof. The intravaginal rings comprise progesterone, a polysiloxane elastomer, and a pharmaceutically acceptable hydrocarbon or glycerol esters of a fatty acid.
    Type: Application
    Filed: October 3, 2013
    Publication date: January 30, 2014
    Applicant: TEVA WOMEN'S HEALTH, INC.
    Inventors: Salah U. AHMED, Jiaxiang TSAO, Anu MAHASHABDE, Diane D. HARRISON